SMS Lifesciences
1,149.20
-56.10(-4.65%)
Market Cap₹347.40 Cr
PE Ratio20.05
IndustryHealthcare
Company Performance:
1D-4.65%
1M+4.82%
6M+1.81%
1Y-22.34%
5Y+79.52%
View Company Insightsright
More news about SMS Lifesciences
14Jul 25
SMS Lifesciences Unveils ₹145 Crore Investment Plan to Boost Specialized API Production
SMS Lifesciences India Limited plans to invest ₹145 crore to expand production of specialized Active Pharmaceutical Ingredients (APIs). The company aims for global sector leadership by FY 2028 through backward integration and USFDA-compliant manufacturing. Recent financial highlights include a 12.67% increase in consolidated revenue to ₹344.72 crore and a 196.04% rise in PAT to ₹18.73 crore for FY 2025. The company plans to expand its product portfolio to over 50 products by FY 2028. Recent regulatory achievements include successful USFDA audits of its manufacturing plants. SMS Lifesciences continues to invest in R&D, spending ₹6.30 crore in FY 2025 and filing seven Drug Master Files with the USFDA.
29May 25
SMS Lifesciences India Reports Decline in Q4 Profit
SMS Lifesciences India's Q4 financial results show a significant decline in net profit to ₹30.00 crore, down 49% from ₹59.00 crore in the previous year. Revenue remained relatively stable at ₹891.00 crore, a slight 1% decrease from ₹900.00 crore. The stark contrast between steady revenue and falling profits suggests potential increases in operational costs or other factors affecting profitability in the pharmaceutical sector.
09May 25
SMS Lifesciences India's API Facility Inspection by USFDA Concludes with One Observation
SMS Lifesciences India Limited's Active Pharmaceutical Ingredient (API) manufacturing facility in Telangana underwent a USFDA inspection, concluding with only one observation. This outcome indicates strong regulatory compliance and could boost market confidence and export potential for the company. The management is expected to address the single observation promptly, reinforcing their commitment to maintaining high-quality standards in API manufacturing.
SMS Lifesciences
1,149.20
-56.10
(-4.65%)
1 Year Returns:-22.34%
Industry Peers
Sun Pharmaceutical
1,586.70
(-2.50%)
Divis Laboratories
5,689.50
(-3.52%)
Cipla
1,499.40
(-0.68%)
Torrent Pharmaceuticals
3,561.00
(+0.83%)
Dr Reddys Laboratories
1,253.10
(-1.73%)
Mankind Pharma
2,482.90
(-1.71%)
Zydus Life Science
975.00
(-4.34%)
Lupin
1,919.80
(-2.23%)
Alkem Laboratories
5,433.00
(-1.36%)
Aurobindo Pharma
1,090.00
(-0.64%)